The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center
M

Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untreated CLL: Clinical Learnings From the CLL14 Study

By The University of Kansas Cancer Center FEATURING Marc Hoffmann
By The University of Kansas Cancer Center FEATURING Marc Hoffmann
543 views
February 1, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

09:50
Incyte

Managing Chronic GVHD Master Class Series: Best Practices at 100 Day…

Feat. C. Cutler
Videos
05:27

ASCO® GI 2025 Insights: Real-World Genomic Testing Performance in CR…

Insights from 2025 ASCO® GI Annual Meeting

H. Li

44 views
06:57

Year in Review 2024: CLL Highlights

The University of Kansas Cancer Center

M. Hoffmann

290 views
14:18

Prioritizing Overall Survival in MF: Longterm Updates From COMFORT-I…

The University of Kansas Cancer Center

A. Yacoub

100 views
13:17

EHA 2024 Insights: Golcadomide, an Oral CELMoD, + R-CHOP in Patients…

Insights from 2024 EHA Annual Meeting

M. Hoffmann

37 views
12:21

SABCS 2023 Insights: "How to Treat TNBC"

Insights from 2023 SABCS

P. Sharma

604 views
09:24

Treatment Sequence in mTNBC

The University of Kansas Cancer Center

P. Sharma

447 views
07:47

ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose Capeci…

Insights from 2023 ASCO® Annual Meeting

C. Bohnenkamp

370 views
14:05

Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untrea…

The University of Kansas Cancer Center

M. Hoffmann

543 views
13:40

Optimizing Use of HER2 Therapies in MBC

SABCS 2021 Conference Coverage on VuMedi

P. Sharma

207 views
10:44

Phase II DREAMM-2: Belantamab Mafodotin in R/R MM

The University of Kansas Cancer Center

A. Abdallah

361 views
07:59

2021 ASCO Updates From LIMBER-313 on Myelofibrosis: Parsaclisib + Ru…

The University of Kansas Cancer Center

A. Yacoub

46 views
08:58

ASCO 2021 Update on mTNBC: Considering Outcomes With Romidepsin / Ci…

The University of Kansas Cancer Center

P. Sharma

364 views
11:45

2021 Updates on MF: Addition of Parsaclisib in Patients With Subopti…

The University of Kansas Cancer Center

A. Yacoub

58 views
06:08

2020 Update on PARPi/Chemo Option in mTNBC: How Effective Is the Add…

The University of Kansas Cancer Center

P. Sharma

132 views